Back to results
US 2012/0251551 A1Published application
Substituted (Heteroarylmethyl)thiohydantoins
AssigneeBayer Pharma Aktiengesellschaft
InventorsUlrich Lücking, Arwed Cleve, Bernard Haendler, Hortensia Faus Gimenez, Silke Köhr, Horst Irlbacher
Life of this patent
Estimating the term…
Abstract
The invention relates to substituted (heteroarylmethyl) thiohydantoin compounds of general formula (I) as described and defined herein, and methods for their preparation, their use for the treatment and/or prophylaxis of disorders, and their use for the preparation of medicaments for the treatment and/or prophylaxis of disorders, in particular of prostate cancer.
Claims17
A compound of general formula (I)
- wherein
- X means nitrogen or a CH group,
- R1 means a fluorinated C1-C3-alkyl-group, an optionally fluorinated C1-C4-alkoxy-group, an optionally substituted hydroxy-C2-C4-alkoxy-group,
- which is substituted with one or two or three substituents selected from the group consisting of methyl, fluorine and trifluoromethyl,
- an optionally substituted methoxy-C2-C4-alkoxy-group,
- which is substituted with one or two or three substituents selected from the group consisting of methyl, fluorine and trifluoromethyl,
- a (tetrahydro-2H-pyranyl)oxy-group,
- an optionally substituted five membered heteroaromatic group selected from the group consisting of pyrrolyl, pyrazolyl, imidazolyl, triazolyl, tetrazolyl, thienyl, oxazolyl, isoxazolyl, furanyl, thiazolyl, oxadiazolyl,
- wherein the five membered heteroaromatic group is substituted with one or two substituents selected from the group consisting of methyl, trifluoromethyl, methoxy-, trifluoromethoxy-, chlorine, fluorine, hydroxy, amino, hydroxymethyl and cyano,
- an optionally substituted five, six, or seven membered heterocyclic group selected from pyrrolidinyl, piperidinyl, piperazinyl, morpholinyl, thiomorpholinyl, diazepanyl, tetrahydrofuranyl, pyrrolinyl, imidazolidinyl and oxazepanyl,
- wherein the five, six, or seven membered heterocyclic group is substituted with one or two or three substituents selected from the group consisting of methyl, trifluoromethyl, hydroxymethyl, fluorine, hydroxy, oxo, oxido, imino, methylimino, cyanoimino, and cyano;
- a residue —O(CH2)n—Y wherein n=2 or n=3, and Y is an optionally substituted five, six, or seven membered heterocyclic group selected from pyrrolidinyl, piperidinyl, piperazinyl, morpholinyl, thiomorpholinyl, diazepanyl, tetrahydrofuranyl, pyrrolinyl, imidazolidinyl and oxazepanyl,
- wherein the five, six, or seven membered heterocyclic group is substituted with one or two substituents selected from the group consisting of methyl, trifluoromethyl, hydroxymethyl, fluorine, hydroxy, oxo, oxido, imino, C1-C4-alkylimino-, and cyano;
- or
- a residue —N═S(═O)R3R4, wherein R3 represents an aryl group or a phenyl group and R4 represents a C1-C4-alkyl or a methyl group;
- R2 means hydrogen, methyl, amino or fluorine,
- or their salts, solvates or salts of solvates.
14 more elements
(canceled)
(canceled)
(canceled)
Dependencies are inferred from the claim text.